Cash Flow - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -128.51 | -41.56 | 139.80 | -93.79 | -50.86 | -25.57 | -10.80 |
| Cash flow from investing | 116.81 | -27.80 | -138.40 | -148.65 | -4.58 | -2.32 | -0.63 |
| Cash flow from financing | 0.89 | 102.96 | 21.04 | 0.48 | 307.46 | 50.09 | 0.04 |
| Change in cash | -10.82 | 33.61 | 22.45 | -241.96 | 252.02 | 22.20 | -11.39 |
Show Quarterly Cash Flow
Cash Flow - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -41.70 | -32.20 | -28.31 | -29.49 | -38.51 | -31.61 | -24.27 | 39.83 | -25.52 | -4.01 | -24.49 | -35.09 | 203.40 | -27.30 | -27.48 | -18.01 | -20.99 | -20.54 | -14.08 | -7.91 | -8.34 | -6.62 | -5.65 | -6.65 | -6.65 |
| Cash flow from investing | 26.99 | 29.12 | 49.11 | 33.80 | 4.78 | 53.37 | -82.93 | -24.38 | 26.15 | 19.04 | -3.74 | -113.26 | -40.44 | 18.79 | -10.13 | 24.23 | -181.53 | -1.32 | -0.81 | -1.54 | -0.91 | -1.45 | -0.24 | -0.32 | -0.32 |
| Cash flow from financing | 0.10 | 0.19 | 0.01 | 0.34 | 0.35 | 1.40 | -0.01 | 101.37 | 0.21 | 0.69 | 0.37 | 0.44 | 19.54 | 0.36 | 0.06 | 0.01 | 0.05 | 190.76 | 0.11 | 0.22 | 116.39 | 0.15 | 24.86 | 12.54 | 12.54 |
| Change in cash | -14.61 | -2.89 | 20.80 | 4.65 | -33.37 | 23.16 | -107.20 | 116.82 | 0.83 | 15.72 | -27.86 | -147.91 | 182.49 | -8.15 | -37.56 | 6.23 | -202.47 | 168.89 | -14.78 | -9.24 | 107.14 | -7.93 | 18.98 | 5.57 | 5.57 |